| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.028 | 0.9 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.027 | 0.9 |